Centene Corporation (CNC) Stock Price & How to Invest

Centene Corporation is a St. Louis-based managed-care organization that administers government-sponsored and subsidized health insurance. It is the largest Medicaid managed-care company in the country (roughly 12.5 million members across about 30 states), the top carrier on the Affordable Care Act Marketplace (around 5.5 million members), and a meaningful Medicare player with about 1.0 million Medicare Advantage members plus roughly 8.1 million prescription-drug-plan members. The company reported total revenue of about $194.8 billion in 2025, and the vast majority of that flows from Medicaid, Marketplace (commercial), and Medicare premiums, making Centene highly exposed to federal and state healthcare policy, reimbursement rates, and medical cost trends.

The investment picture is defined by a sharp reset. In mid-2025 Centene withdrew its full-year guidance after an independent actuarial review found its ACA Marketplace risk-adjustment and morbidity assumptions were too optimistic, and the stock fell about 40% in a single session, hitting multi-year lows. Since then, the story has been about stabilization: Q1 2026 came in ahead of expectations (adjusted EPS of roughly $3.37 on about $49.9 billion of revenue) and management raised full-year 2026 guidance to roughly $187.5 to $191.5 billion of revenue with adjusted EPS expected above $3.40. The stock trades near the low $60s, a lower multiple than higher-margin peers, reflecting both the depressed earnings base and ongoing uncertainty around Medicaid funding and cost trends.

Centene withdrew its 2025 guidance and its stock fell roughly 40% in a single day in July 2025 after actuaries flagged that its ACA Marketplace assumptions were too aggressive, so guidance credibility and forecasting accuracy are live concerns. Medicaid is the single largest source of revenue, and federal legislation enacted in 2025 is projected to cut a large amount of Medicaid funding over the coming years, which could reduce enrollment and pressure rates. Medical cost trends in behavioral health, home health, and high-cost drugs have run hotter than expected, and results are sensitive to state rate negotiations, redeterminations, and ACA subsidy policy. The stock is more volatile than the broader market, and the earnings base is depressed relative to prior peaks.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Centene Corporation's investor relations page or your broker.

• Revenue (2025): ~$194.8B
• 2026 revenue guidance: ~$187.5B to $191.5B
• Q1 2026 adjusted EPS: ~$3.37
• 2026 adjusted EPS guidance: ~>$3.40
• Share price (mid-July 2026): ~$64
• Market cap: ~$31B

Centene trades on a low earnings multiple relative to higher-margin managed-care peers, reflecting a depressed post-2025 earnings base and elevated uncertainty. Revenue is enormous (near $195 billion) but health insurance is a thin-margin business, so small changes in the health-benefits ratio move earnings sharply. The 2026 consensus EPS sits near the mid-$3 range.

There are three common ways to get CNC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so CNC sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where CNC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

CNC is a scale player in Medicaid and Marketplace insurance that is working to rebuild margins and credibility after pulling its 2025 guidance, and its story now hinges on cost trends and Medicaid policy.

Whether CNC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CNC a buy?, and where the stock could go from here in the CNC stock forecast.

For income investors, whether CNC pays a dividend and how the payout looks is covered in does CNC pay a dividend?